EUCTR2005-003096-20-IT进行中（未招募）不适用
se of peg-filgrastim in severe chronic neutropenia
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
Unknown
2 期
Mecapegfilgrastim(PEG-G-CSF) for Prophylaxis of Chemotherapy-induced Neutropenia in Patients With LymphomaChemotherapy-induced NeutropeniaLymphomaNCT04460508The First Hospital of Jilin University170
已完成
2 期
Plinabulin iv Solution in Prevention of TAC Induced NeutropeniaChemotherapy-induced NeutropeniaNCT04227990BeyondSpring Pharmaceuticals Inc.115
进行中（未招募）
2 期
Mecapegfilgrastim for the Prevention of Dalpiciclib -Induced Neutropenia in Advanced Breast CancerMetastatic Breast CancerNCT05463601Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University132
招募中
4 期
Reducing Neutropenia Incidence With Pegfilgrastim Administration on Day 3 After ChemotherapyBreast NeoplasmsNCT05949333Eunseong Medical Foundation Good GANG-AN HOSPITAL100
已完成
不适用
Optimal timing of pegfilgrastim in DCF regimen for advanced esophageal canceresophageal cancerJPRN-UMIN000023393Kyoto Prefectural University of Medicine, Gatroenterology and Hepatology23